NALIRI

DRUG2 trials

Sponsors

Zhejiang Cancer Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Conditions

Biliary Tract Cancer (BTC)Locally Advanced Rectal Cancer

Phase 2

A Randomized, Two-cohort, Prospective Phase II Clinical Study of the Second-line Treatment of Advanced Biliary System Tumors With Liposomal Irinotecan (II) Combination Regimen

Not yet recruitingNCT07099794

Cancer Institute and Hospital, Chinese Academy of Medical SciencesBiliary Tract Cancer (BTC)

Start: 2025-08-01End: 2029-08-31Target: 90Updated: 2025-08-01

Phase 3

Irinotecan Liposomes in Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer

Not yet recruitingNCT07074353

Zhejiang Cancer HospitalLocally Advanced Rectal Cancer

Start: 2025-07-20End: 2030-07-01Target: 360Updated: 2025-07-25